Category: Drug Discovery

  Nvidia-Backed Iambic Therapeutics Launches IPO: Can AI Transform Drug Discovery? Iambic Therapeutics is moving toward a US stock-market de...

  Danaher to Launch AI-Powered Autonomous Research Lab in 2027: What It Means for AI and Biotech Danaher Corporation (NYSE: DHR) is taking ...

  CSL Partners With AWS on AI for Drug Research and Development Australian biotechnology company CSL Limited (ASX: CSL) is partnering with ...